XTNT — Xtant Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- $99.41m
- $126.86m
- $117.27m
- 55
- 74
- 91
- 87
Annual income statement for Xtant Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 53.3 | 55.3 | 58 | 91.3 | 117 |
| Cost of Revenue | |||||
| Gross Profit | 34.4 | 32.5 | 32.1 | 55.5 | 68.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 54.1 | 59.1 | 64.7 | 89.8 | 129 |
| Operating Profit | -0.751 | -3.85 | -6.75 | 1.54 | -12.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.73 | -4.85 | -8.42 | -1.04 | -16.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.02 | -4.85 | -8.48 | 0.66 | -16.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.02 | -4.85 | -8.48 | 0.66 | -16.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.02 | -4.85 | -8.48 | 0.66 | -16.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.246 | -0.057 | -0.09 | -0.055 | -0.123 |